loader image
Monday, March 18, 2024
62.3 F
McAllen
We Welcome your Press Release
- Advertisement -

DHR Health Neuroscience Institute Recognized as a Partner in MS Care By the National MS Society

Translate to Spanish or other 102 languages!

A prestigious recognition, the National MS Society awards this title to a handful of healthcare providers each year

- Advertisement -
Dr. Roberto Alejandro Cruz

Mega Doctor News

Edinburg, Texas  – On January 4, 2020  DHR Health Neuroscience Institute, a leading provider of care for people living with multiple sclerosis (MS) in the Rio Grande Valley, was officially recognized as a Partner in MS Care through the National Multiple Sclerosis Society’s Partners in MS Care program. 

As the first and only partner in MS Care in the Rio Grande Valley and the only facility to offer a board certified and fellowship trained Multiple Sclerosis specialist in the region, this formal recognition honors the institute’s commitment to continuously demonstrating exceptional expertise and the coordinated care necessary to treat people living with MS. 

- Advertisement -

“At DHR Health we are proud to offer National MS Society quality standards and we are dedicated to providing personalized care to every MS patient by offering the newest available disease modifying therapies,” said Roberto Alejandro Cruz, M.D.,  at DHR Health Neuroscience Institute.

The Society’s Partners in MS Care program recognizes committed providers, like Roberto Alejandro Cruz, MD, whose practices support the Society’s initiative of affordable access to high quality MS healthcare for everyone living with MS – regardless of geography, disease progression, and other disparities.

“We are proud to partner with DHR Health Neuroscience Institute to enhance quality and dedicated care for the people who live with MS in the Rio Grande Valley” said Anna Moss National MS Society Manager of Healthcare Provider Engagement, Advocacy and Healthcare Access, “In earning this recognition, DHR Health Neuroscience Institute has demonstrated extraordinary leadership in MS care, making a tremendous impact on the nearly 1 million people living with MS in our country.”

DHR Health Neuroscience Institute provides care for patients affected by a stroke, epilepsy, movement disorders, brain and spine injuries as well as other neurological issues.  Also home to the region’s only BlueCross BlueShield of Texas Blue Distinction Center for Spine Surgery with care provided by the regions’ only fellowship-trained spine surgeons, DHR Health Neuroscience Institute demonstrates leadership in expert care for evaluating and treating the most complex and challenging brain and nervous system disorders in the Rio Grande Valley.

- Advertisement -

Early and ongoing treatment can make a difference for people with multiple sclerosis. For more information call the DHR Health Neuroscience Institute at (956) 362-8500. 

About DHR Health

DHR Health was founded in 1997 to help over 1.2 million residents resolve limited health care access challenges in a community that lacked public and county hospitals. Today, it is a modern, 500+ bed full-service health system serving over 280,000 patients annually, with 5500+ employees, over 650 physicians and more than 1,400 nurses dedicated to offering a full-continuum of care in over 70 different specialties and subspecialties. DHR Health proudly boasts the best specialty care in the region, a 24/7 functioning level-one trauma center, a robust clinical research division, and developing graduate medical education programs. DHR Health has revolutionized the health care landscape of the Rio Grande Valley and continues to raise the standard of care and transform the health care delivery model for the benefit all local residents. To learn more, visit www.DHRHealth.com

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms vary from person to person and range from numbness and tingling, to walking difficulties, fatigue, dizziness, pain, depression, blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with three times more women than men being diagnosed with the disease. A recent study led by the National MS Society estimates that nearly 1 million people are living with MS in the United States; twice as many than previously thought.

About the National Multiple Sclerosis Society

The Society mobilizes people and resources so that everyone affected by multiple sclerosis can live their best lives as we stop MS in its tracks, restore what has been lost and end MS forever. Last year, the Society invested $40 million in MS research with more than 360 active projects around the world. Through its comprehensive nationwide network of services, the Society devoted $100 million to help more than one million people affected by MS connect to the people, information and resources needed to live their best lives. We are united in our collective power to do something about MS now and end this disease forever. Learn more at nationalMSsociety.org.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Vannie E. Cook Children’s Cancer and Hematology Clinic: “Eat a Sub: Help Wipe Out Kids’ Cancer”

Since the Month of Giving began in 2011, Jersey Mikes has raised more than $88 million for local charities. 

Greg Manteufel’s Triumph Over a Life-Threatening Infection  

Greg's initial symptoms of fever and limb weakness were the early signs of a rare and severe blood infection caused by Capnocytophaga canimorsus, a bacterium commonly found in the mouths of dogs and cats.

Salm Partners, LLC, Recalls Johnsonville Polish Kielbasa Turkey Sausage Products

The products subject to recall bear establishment number "P-32009" printed on the side of the packaging. These items were shipped to retail locations nationwide.

FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity 

Obesity or overweight affect approximately 70% of American adults.
- Advertisement -
×